Moalem Weitemeyer assisted Eir Ventures in the transaction. SD Immunotech ApS (“ISD”), a biotech company developing new anti-inflammatory treatments, announced that Eir Ventures have completed an...
This content is for Standard 1 Year members only. LoginJoin Now